Vertex Pharmaceuticals
VRTX
VRTX
707 hedge funds and large institutions have $41.8B invested in Vertex Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 287 increasing their positions, 238 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 716 → 707 (-9)
8% less capital invested
Capital invested by funds: $45.2B → $41.8B (-$3.4B)
18% less call options, than puts
Call options by funds: $253M | Put options by funds: $307M
Holders
707
Holding in Top 10
18
Calls
$253M
Puts
$307M
Top Buyers
| 1 | +$280M | |
| 2 | +$248M | |
| 3 | +$145M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$122M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$102M |
Top Sellers
| 1 | -$170M | |
| 2 | -$153M | |
| 3 | -$127M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$125M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$84.7M |